Press Releases
Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and Highlights
Ceapro Inc. to Present at the April 2020 Virtual Investor Summit
Ceapro Inc. Receives Research License from Health Canada Controlled Substances and Cannabis Branch
Ceapro Inc. to Present at Noble Capital Markets’ 16th Annual Investor Conference
Ceapro Inc. Announces Approval from Health Canada for Protocol Expansion of Current Clinical Study Assessing Beta Glucan as a Cholesterol-Lowering Agent
Ceapro Inc. Secures DTC Eligibility for Publicly Traded Shares Under Ticker OTCQZ: CRPOF
Ceapro Announces Grant of Stock Options and Restricted Share Units
Ceapro Inc. Announces Publication of Results for a New PGX Processed Chemical Complex in the Journal of Supercritical Fluids
Ceapro Inc. Reports 2019 Third Quarter Financial Results and Operational Highlights
